Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pileri

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
Leukemia|March 26, 2014
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphomaP Corradini, U Vitolo, A Rambaldi, et al.
Virchows Archiv : an International Journal of Pathology|August 8, 2019
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.)Arianna Di Napoli, D Remotti, C Agostinelli, et al.
Virchows Archiv : an International Journal of Pathology|October 31, 2019
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefitArianna Di Napoli, D Remotti, C Agostinelli, et al.
Blood|January 15, 1996
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's diseaseB Falini, B Bigerna, L Pasqualucci, et al.
The American Journal of Pathology|May 1, 1996
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal regionL Flenghi, B Bigerna, M Fizzotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphomaP L Zinzani, M Tani, A Pulsoni, et al.
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
Gut|December 14, 2005
Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradicationH Ye, L Gong, H Liu, et al.
Pathologica|June 23, 2006
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics]M Paulli, T Artusi, C D Baroni, et al.
Leukemia|September 24, 2011
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarraysM Ciccone, C Agostinelli, G M Rigolin, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Leukemia|March 26, 2014
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphomaP Corradini, U Vitolo, A Rambaldi, et al.
Virchows Archiv : an International Journal of Pathology|August 8, 2019
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.)Arianna Di Napoli, D Remotti, C Agostinelli, et al.
Virchows Archiv : an International Journal of Pathology|October 31, 2019
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefitArianna Di Napoli, D Remotti, C Agostinelli, et al.
Blood|January 15, 1996
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's diseaseB Falini, B Bigerna, L Pasqualucci, et al.
The American Journal of Pathology|May 1, 1996
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal regionL Flenghi, B Bigerna, M Fizzotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphomaP L Zinzani, M Tani, A Pulsoni, et al.
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
Gut|December 14, 2005
Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradicationH Ye, L Gong, H Liu, et al.
Pathologica|June 23, 2006
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics]M Paulli, T Artusi, C D Baroni, et al.
Leukemia|September 24, 2011
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarraysM Ciccone, C Agostinelli, G M Rigolin, et al.
Pageof 25